Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Minimally invasive management of pilonidal sinus disease by phenol intra-cavitary application: A single surgeon experience

Bora Barut.




Abstract
Cited by 1 Articles

Aim: The objective of the present study is to share single surgeon’s experience in management of pilonidal sinus disease by phenol application.
Material and Methods: Fifty-two patients, who were treated by phenol application for pilonidal sinus disease between September 2010 and August 2013, were analyzed retrospectively.
Results: During this period phenol application was performed in 52 patients due to pilonidal sinus disease. Phenol application was performed three times for each patient (1st, 2nd and 7th days). Forty-eight (92%) patients were male and 4 (8%) female with a mean age of 22 years (range: 16-38 y). The mean follow-up period of the patients was 11 months (range: 4-18 m). Three (5.7%) patients had a recurrence and the mean follow up period was 11 months.
Conclusion: Many surgical techniques are available in the treatment of pilonidal sinus disease. But all of them remain controversial due to recurrence and complication rates. Phenol treatment is easily applicable and has low costs with acceptable recurrence rates and provides rapid healing. For this reason, we suggest this non-invasive treatment in pilonidal sinus disease.

Key words: Pilonidal sinus disease; phenol; minimally invasive; treatment experience.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.